Skip to main content
Shlomo Melmed, MD, Endocrinology, Los Angeles, CA

Shlomo Melmed MD

Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology


Professor and Dean

Join to view full profile
  • 8700 Beverly BlvdLos Angeles, CA 90048

  • Phone+1 310-423-2830

  • Fax+1 310-423-2819

Dr. Melmed is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesFellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1980
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1977 - 1980
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1970

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors:LA Area Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Consensus Statement on Acromegaly Therapeutic Outcomes  
    David R Clemmons, Shlomo Melmed, Anne Klibanski, Nature

Lectures

  • Pituitary-Tumor Endocrinopathies 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Optimizing Health Outcomes in Acromegaly: Comorbidity and Cancer Surveillance Beyond IGF-1 (Repeat) 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Optimizing Health Outcomes in Acromegaly: Comorbidity and Cancer Surveillance Beyond IGF-1 
    ENDO 2019 - New Orleans, LA - 3/24/2019

Other

Authored Content

  • Pituitary-Tumor EndocrinopathiesMarch 2020

Press Mentions

  • Cedars-Sinai Appoints Inaugural Chief Physician
    Cedars-Sinai Appoints Inaugural Chief PhysicianJuly 24th, 2026
  • Crinetics Announces FDA Approval of PALSONIFY™ (Paltusotine) for the Treatment of Adults with Acromegaly
    Crinetics Announces FDA Approval of PALSONIFY™ (Paltusotine) for the Treatment of Adults with AcromegalySeptember 25th, 2025
  • Urologic Oncologist Hyung Kim, MD, Named Chair of Cedars-Sinai Department of Urology
    Urologic Oncologist Hyung Kim, MD, Named Chair of Cedars-Sinai Department of UrologyFebruary 2nd, 2023

Grant Support

  • Mechanisms for GH action on epithelial cellsCEDARS-SINAI MEDICAL CENTER2018–2028
  • Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)CEDARS-SINAI MEDICAL CENTER2018–2025
  • Training Program in Endocrinology, Diabetes, and MetabolismCEDARS-SINAI MEDICAL CENTER1999–2025
  • GHNIDDKPresent

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: